Marvin & Palmer Associates Inc Merck & Co., Inc. Transaction History

Marvin & Palmer Associates Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$83.49 - $94.64 $8.85 Million - $10 Million	105,965 New	105,965 $9.66 Million
Q4 2019 Feb 11, 2020	SELL	$77.58 - $87.54 $5.01 Million - $5.65 Million	-64,549 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$76.08 - $82.93 $121,271 - $132,190	1,594 Added 2.53%	64,549 $5.43 Million
Q2 2019 Aug 19, 2019	SELL	$69.84 - $81.59 $228,865 - $267,370	-3,277 Reduced 4.95%	62,955 $5.28 Million
Q4 2018 Feb 12, 2019	BUY	$65.24 - $75.71 $4.32 Million - $5.01 Million	66,232 New	66,232 $5.06 Million

3,873

1.89B

16.1M

13.6M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $219B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Marvin & Palmer Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Marvin & Palmer Associates Inc with notifications on news.